Items 121 ~ 130 of 5389, Page 13 of 539 
  04/19/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA approves first generic naloxone nasal spray to treat opioid overdose
- Agency is also taking new steps to support development of over-the-counter and additional generics of naloxone to help reduce opioid overdose deaths, increase access to emergency treatment
  04/17/2019 WHO - Public Health
WHO releases first guideline on digital health interventions
- Digital health interventions are not sufficient on their own /
  04/17/2019 Medtronic - Business
Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease
- Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London. The new data demonstrate durable and consistent long-term outcomes of the Medtronic VenaSeal(TM) Closure System in treating patients with chronic venous disease.
  04/16/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA takes action to protect women’s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to remove all devices from the market
  04/16/2019 Radiological Society of North America - Professional Issues
Radiology Publishes Roadmap for AI in Medical Imaging
- In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging. The workshop was co-sponsored by NIH, the Radiological Society of North America (RSNA), the American College of Radiology (ACR) and The Academy for Radiology and Biomedical Imaging Research (The Academy). The organizers aimed to foster collaboration in applications for diagnostic medical imaging, identify knowledge gaps and develop a roadmap to prioritize research needs. The group''s research roadmap was published today as a special report in the journal Radiology.
  04/16/2019 American Cancer Society - Clinical
FDA Approves First Targeted Therapy for Bladder Cancer
- The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.
  04/15/2019 American Cancer Society - Clinical
FDA Warns of Cancer Risk in a Type of Uterine Fibroid Surgery
- The US Food and Drug Administration (FDA) is warning women and doctors about the risks of a certain technique used in surgery for uterine fibroids.
  04/13/2019 WHO - Public Health
At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices
- WHO to continue to facilitate countries' information-sharing to improve transparency on prices
  04/12/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA approves first targeted therapy for metastatic bladder cancer
  04/11/2019 U.S. FOOD & DRUG ADMINISTRATION - Government
FDA orders important safety labeling changes for Addyi

<<  <  [11]  [12]  [13[14]  [15]  [16]  [17]  [18]  [19]  [20]  >  >>